Clinical Trials for HER2 Negative Breast Cancer

Find clinical trials for her2 negative breast cancer. Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy

NCT ID: NCT06953882

This clinical trial is looking at a new way to treat a specific type of breast cancer called ER-positive, HER2-negative breast cancer. It aims to find out if patients can safely skip chemotherapy a...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: New Haven, Connecticut, United States

Reverse HER2-negative Immune Resistant Breast Cancer

NCT ID: NCT06731140

This clinical trial, called the "Reverse Luminal Immune Resistant Breast Cancer" study, is exploring a new treatment approach for women with luminal breast cancer who have not responded well to pre...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

NCT ID: NCT05824975

This clinical trial is studying a new treatment called GI-102 for patients with advanced solid tumors, which are cancers that have spread beyond their original site. The main goal of the study is t...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States, Scottsdale, Arizona, United States +10 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions